申请人:Alnylam Pharmaceuticals, Inc.
公开号:EP3919619A1
公开(公告)日:2021-12-08
The present invention relates to a multi-targeted molecule comprising a first double-stranded siRNA molecule and a second double-stranded siRNA molecule, wherein the first siRNA and the second siRNA are covalently linked to each other, and wherein at least one ligand is conjugated with the multi-targeted molecule.
本发明涉及一种多靶点分子,包括第一双链 siRNA 分子和第二双链 siRNA 分子,其中第一 siRNA 和第二 siRNA 相互共价连接,并且至少有一种配体与多靶点分子共轭。